SureTrader SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

Apricus Biosciences, Inc. (APRI)

APRI RSS Feed
Add APRI Price Alert      Hide Sticky   Hide Intro
Moderator: carlodb1978, mecosmo2, Chillin up north
Search This Board:
Last Post: 1/22/2017 9:17:18 AM - Followers: 199 - Board type: Free - Posts Today: 1

Apricus Biosciences, Inc. (APRI) 

 

 

http://www.apricusbio.com/

 

 

 

 

Company Address:

11975 El Camino Real, Suite 300
San Diego, CA 92130
T (858) 222-8041

 CIK:   0001017491

Apricus Website:    http://www.apricusbio.com/index.html

 

 
 

NexACT® - Multi-Route Drug Delivery Technology

NexACT® Multi-Route drug delivery technology facilitates compounds crossing the lipid bilayer and yet biodegrades in vivo to natural amino acids and natural fatty acids.

This technology is useful for:
  • Penetrating, proprietary, topical & transdermal formulations.
    Improving oral bioavailability of poorly soluble, poorly permeating compounds (BCS class 2-4)
    Delivering siRNA therapeutics into the cells; in vivo validated
    Development of more effective, penetrating cosmeceutic formulations
    Preservative

The safety and permeation properties of this proprietary drug delivery technology was demonstrated in the Vitaros® product which was approved for the treatment of erectile dysfunction in November 2010 by Health Canada, and approved by the European Union in June 2013.  Vitaros has been launched in all European Union countries by partner pharmaceutical companies.  Additional agreements for marketing Vitaros have been established.  For more information see the company's most recent 10K SEC filing.

In September 2015 the company anounced an agreement with Allergan to reacquire marketing rights for Vitaros in the U.S.  The company expects to resubmit a filing for FDA approval of Vitaros in the second half of 2016.  For more information see the company's most recent 10K SEC filing.


The company expects to initiate a Phase IIb clinical trial for RayVa to treat Reynaud's Syndrome in the second half of 2016.

In October 2014, the company acquired U.S. development and licensing rights to Fispemifene, a Selective Estrogen-Receptor Modulator (SERM) for treatment of secondary hypogonadism.  In March 2016 the company discontinued development Fispemifene after disappointing Phase IIb results.
.

 Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001017491&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Share Structure:
Outstanding Shares
 61,78M

Authorized Shares
75,000,000
  

Investor Relations:
ir@apricusbio.com
Tel: +1-858 222-8041

Matthew Beck
The Trout Group
:(646)378 2933

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 


                                                                           
Image result for vitaros                                                  

Image result for vitaros

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
APRI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
APRI News: Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico 01/18/2017 07:00:25 AM
APRI News: Apricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in Mexico 01/18/2017 07:00:00 AM
APRI News: Securities Registration: Employee Benefit Plan (s-8) 01/04/2017 04:09:00 PM
APRI News: Apricus Biosciences Promotes Mary Naggs to Vice President, General Counsel 01/03/2017 07:00:16 AM
APRI News: Apricus Biosciences Promotes Mary Naggs to Vice President, General Counsel 01/03/2017 07:00:00 AM
PostSubject
#26780   R2 Please post a report on your RE mecosmo2 01/22/17 09:17:18 AM
#26779   Lmao. This board is fun imo Rogerthat1 01/21/17 01:35:42 PM
#26778   I am one of those tourists, and next r2g2 01/21/17 01:28:24 PM
#26777   Not to worry r2 they will survive. . mecosmo2 01/21/17 11:05:04 AM
#26776   Lol Aprilov 01/21/17 09:00:48 AM
#26775   Lol Rogerthat1 01/20/17 09:46:30 PM
#26774   This message may be, possibly, the first signal wam3 01/20/17 08:44:06 PM
#26773   One wonders where this is going... Is anyone r2g2 01/20/17 05:57:38 PM
#26772   Still up 60% from before the news and PuuliTuku 01/19/17 02:55:24 PM
#26771   Under the terms of the agreement, Apricus mecosmo2 01/19/17 11:51:48 AM
#26770   We need a strong news before the kick off carlodb1978 01/19/17 08:43:12 AM
#26768   http://investorshub.advfn.com/boards/read_msg.aspx?message_id=127941857 alchemytrader 01/18/17 11:13:27 PM
#26767   Day Traders... Buyers and Sellers. Not investors. Reaver04 01/18/17 09:25:22 PM
#26766   So loads and loads of people buying lower PuuliTuku 01/18/17 05:17:06 PM
#26765   Day traders Me2Greedy 01/18/17 05:13:08 PM
#26764   With so many shares we should have been carlodb1978 01/18/17 05:04:35 PM
#26763   Btw after-hours trading looking great, check it out. PuuliTuku 01/18/17 05:04:22 PM
#26762   I dont get it either, with float this PuuliTuku 01/18/17 05:03:13 PM
#26761   APRI awesome AM from approx. $2.00 average to cjstocksup 01/18/17 05:02:26 PM
#26760   * * $APRI Video Chart 01-18-17 * * ClayTrader 01/18/17 04:21:35 PM
#26759   Wish I had.....PS : Nice entry on URG nowwhat2 01/18/17 04:04:22 PM
#26758   He is gone since days Very suspicious it does carlodb1978 01/18/17 01:54:01 PM
#26757   Low float :) stock1ace1 01/18/17 01:21:41 PM
#26756   casinokid you are very quiet shaggy2691 01/18/17 01:20:38 PM
#26755   I'm out nice trade BoilerRoom 01/18/17 12:28:32 PM
#26754   wouldn't be surprised to see 2 to 3 oldcoach19 01/18/17 12:18:39 PM
#26753   Wow I left way too early lol this QUANTUM314 01/18/17 12:13:10 PM
#26752   nvax# is next $$$ myop kingsransome 01/18/17 12:11:29 PM
#26751   Looks like they need money. Stock offering today/tomorrow? Tim696969 01/18/17 12:11:08 PM
#26750   Yes, my sell has executed. Will watch for HUSTLA 01/18/17 11:58:48 AM
#26749   $4's!!! [SMART MONEY] 01/18/17 11:57:14 AM
#26748   now im afraid they may increase shares to kingsransome 01/18/17 11:41:57 AM
#26747   Looks like a 30 million share day! With mecosmo2 01/18/17 11:31:46 AM
#26746   Darn real boner. I sold at 3.18 lol Rogerthat1 01/18/17 11:23:33 AM
#26745   A banner day for APRI longs. Hope growtheport 01/18/17 11:19:34 AM
#26744   Could break 4.00 today. Great news out this morning. HUSTLA 01/18/17 11:17:19 AM
#26743   New HOD $3.76. Go $APRI !!!! psnvestr 01/18/17 11:15:29 AM
#26742   CHART [SMART MONEY] 01/18/17 11:14:55 AM
#26741   Hey fellas, know what? The 35m nasdaq-minimum is PuuliTuku 01/18/17 11:12:10 AM
#26740   20 mlns Can someone explain how can they exchange carlodb1978 01/18/17 10:57:09 AM
#26739   Only $20 to go to break even on psnvestr 01/18/17 10:55:24 AM
#26738   Running closing in on 4'ss Tdash 01/18/17 10:46:14 AM
#26737   First move on the road back to $60M psnvestr 01/18/17 10:43:03 AM
#26736   Lmao Rogerthat1 01/18/17 10:27:34 AM
#26735   3.19 Up 1.68(111.25%) 10:10AM EST - Nasdaq Real mecosmo2 01/18/17 10:19:50 AM
#26734   I'm in.. Liquid1974 01/18/17 10:08:54 AM
#26733   $3'S ARE UP [SMART MONEY] 01/18/17 10:06:58 AM
#26732   looks like 4.30 may clear kingsransome 01/18/17 10:02:56 AM
#26731   as well as Canada, then USA approval in 2018 eicoman 01/18/17 10:02:10 AM
#26730   APRI bONER ACTIVATION!!!! [SMART MONEY] 01/18/17 09:44:25 AM
PostSubject